Case Report
Volume 5 Issue 1 - 2022
The Role of Butyrate Fermented in Aloe Vera Gel to Neurological Dysfunction in Post-acute COVID-19
Akira Yagi1*, Megumi Hasegawa2 and Miiko Mikami3
1Special Advisor of Japan Aloe Science Association, Emeritus Professor of Fukuyama University in Hiroshima, Japan
2Pharmacist, Kampo Pharmacy Grace-Meg-Salon, Toshima-ku, Tokyo, Japan
3Former a Senior Nursing Officer, JASA-Authorized Lecturer, Sapporo, Hokkaido, Japan
*Corresponding Author: Akira Yagi, Special Advisor of Japan Aloe Science Association, Emeritus Professor of Fukuyama University in Hiroshima, Japan.
Received: December 08, 2021; Published: December 31, 2021



Abstract

COVID-19 is now recognized as a multi-organ disease with a broad spectrum of manifestation. COVID-19 survivors have described prolonged malaise, diffuse myalgia, depressed symptoms, and non-restorative sleep as a post-viral syndrome. In this study, we looked at how butyrate fermented in aloe vera gel helped post-acute COVID-19 patients with neuropsychiatric symptoms such sadness, anxiety, and sleeplessness. The adjuvanticity of aloe vera gel to COVID-19 vaccination and the mitigation of side effects from Covid-19 immunisation after surgery were demonstrated in case studies.

Keywords: Fermented Butyrate; Aloe Vera Gel; Neurological Dysfunction

References

  1. Rishi P., et al. “Diet, gut microbiota and COVID-19”. Indian Journal of Microbiology 4 (2020): 1-10.
  2. Zuo T., et al. “Alterations in gut microbiota of patients with COVID-19 during time of hospitalization”. Gastroenterology 159 (2020): 944-955.
  3. Yeoh YK., et al. “Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19”. Gut Microbiota4 (2021): 698-706.
  4. Tang L., et al. “Clinical significance of the correlation between changes in the major intestinal bacteria species and COVID-19 severity”. Engineering 6 (2020): 1178-1181.
  5. A Kabbash., et al. “Exploratory approaches for the use of Aloe for COVID-19 treatment: Prevention and mitigation effect”. Journal of Diabetes Research Reviews and Reports 4 (2020): 1-6.
  6. Yagi M., et al. “Prophylactic role of Aloe components, butyrate fermented, micrnas, and hyaluronan on Alzheimer’s disease, Parkinson’s disease, and osteoarthritis in knee joints: Case reports of aloe vera juice ingestion producing intestinal butyrogenic microbiome and bone regeneration”. Journal of Gastroenterology1 (2021): 3398-3406.
  7. A Yagi., et al. “Epigenetic roles of short chain fatty acids a beneficial modulator in the neuroendocrine systems: Case reports: Influence of aloe vera juice to brain homeostasis”. Journal of Gastroenterology5 (2021): 3571-2576.
  8. Caspani G and Swann J. “Small talk: microbial metabolites involved in the signaling from microbiota to brain”. Current Opinion in Pharmacology 48 (2019): 99-106.
  9. Valles-Colomer M., et al. “The neuroactive potential of the human gut microbiota in quality of life and depression”. Nature Microbiology 4 (2019): 623-632.
  10. Patnala R., et al. “HDAC inhibitor sodium butyrate-mediated epigenetic regulation enhances neuroprotective function of microglia during ischemic stroke” Molecular Neurobiology 8 (2017): 6391-6411.
  11. Van de Wouw M., et al. “Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut alterations”. Journal of Physiology 20 (2018): 4923-4944.
  12. Batty GD., et al. “Psychosocial factors and hospitalizations for COVID-19: Prospective cohort study based on a community sample”. Brain, Behavior, and Immunity 89 (2020): 569-578.
  13. Sajdel-Sulkowska EM. “Neuropsychiatric ramifications of COVID-19; Short chain fatty acid deficiency and disturbance of microbiota-gut-brain axis signaling”. BioMed Research International (2021): 15.
  14. Wu M., et al. “Associations between disordered gut microbiota and changes of neurotransmitters and short-chain fatty acids in depressed mice”. Translational Psychiatry 10 (2020): 350.
  15. Wei Y., et al. “Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene”. International Journal of Neuropsychopharmacology 2 (2014): pyu032.
  16. Fuchikami M., et al. “The potential use of histone deacetylase inhibitors in the treatment of depression”. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64 (2016): 320-324.
  17. Bojovic K., et al. “Gut microbiota dysbiosis associated with altered production of short chain fatty acids in children with neurodevelopmental disorders”. Frontiers in Cellular and Infection Microbiology 10 (2020): 223.
  18. Ojeda J., et al. “Gut microbiota interaction with the central nervous system throughout life”. Journal of Clinical Medicine 10 (2021): 1239.
  19. Li S., et al. “The role of bacteria and its derived metabolites in chronic pain and depression: Recent findings and research progress”. The International Journal of Neuropsychopharmacology 1 (2020): 26-41.
  20. Huuskonen J., et al. “Regulation of microglia inflammatory response by sodium butyrate and short chain fatty acids”. British Journal of Pharmacology 5 (2004): 874-880.
  21. Liu J., et al. “Sodium butyrate exerts protective effect against Parkinson’s disease in mice via stimulation of glucagon like peptide-1”. Journal of the Neurological Sciences 381 (2017): 176-181.
  22. A Yagi., et al. “Prophylactic role of aloe components, butyrate fermented, micrans, and hyaulonan on Alzheimer’s disease, Parkinson’s disease, and osteoarthritis in knee joints: Case reports of aloe vera juice ingestion producing intestinal butyrogenic microbiome and bone regeneration”. Journal of Gastroenterology1 (2021): 3385-3406.
  23. Nagpal R., et al. “Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer’s disease markers in subjects with mild cognitive impairment”. EBio Medicine 47 (2019): 529-542.
  24. Ling Z., et al. “Structural and functional dysbiosis of fecal microbiota in Chinese patients with Alzheimer’s disease”. Frontiers in Cell and Developmental Biology 8 (2021): 634069.
  25. Ueda A., et al. “Identification of Faecalibacterium prausnitzii strains for gut microbiome-based intervention in Alzheimer’s-type dementia”. Cell Reports Medicine 9 (2021): 100398.
  26. Gopal AB., et al. “Silent hypoxia in COVID-19: a gut microbiota connection”. Current Opinion in Physiology 23 (2021): 100456.
  27. Barichello T., et al. “Sodium butyrate prevents memory impairment by Re-establishing BDNF and GDNF expression in experimental pneumococcal meningitis”. Molecular Neurobiology 1 (2015): 734-740.
  28. Duan C., et al. “Gut commensal-derived butyrate reverse obesity-induced social deficits and anxiety-like behaviors via regulation of microglial homeostasis”. European Journal of Pharmacology 908 (2021): 174338.
  29. Huang C., et al. “6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study”. Lancet10270 (2021): 220-232.
  30. Szentirmai E., et al. “Butyrate, a metabolite of intestinal bacteria, enhances sleep”. Scientific Reports 9 (2019): 7035.
  31. Ghannoum MA., et al. “A microbiome-driven approach to combating depression during the COVID-19 pandemic”. Frontiers in Nutrition 8 (2021): 672390.
  32. Al Kassaa I., et al. “High association of COVID-19 severity with poor gut health score in Lebanese patients”. PLoS One10 (2021): e0258913.
  33. Nalbandian A., et al. “Post-acute COVID-19 syndrome”. Nature Medicine 27 (2021): 601-615.
  34. A Yagi. “Aloe vera high molecular weight fraction as carbohydrate-based immune adjuvants”. Journal of Gastroenterology5 (2013): 568-570.
  35. A Yagi and H Abe. “Beneficial efficacy of histone deacetylase inhibitor butyrate and histone crotonylation to human immunodeficiency virus-infected subjects”. Journal of Gastroenterology1 (2020): 3054-3058.
Citation: Akira Yagi., et al. “The Role of Butyrate Fermented in Aloe Vera Gel to Neurological Dysfunction in Post-acute COVID-19”. EC Clinical and Medical Case Reports 5.1 (2022): 36-45.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events

January Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before February 13, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.